Atif J. Khan
Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Atif J. Khan

Hematology | Oncology
White River Health System
White River Health System, Inc.
1710 Harrison St, 
Batesville, AR 
Accepting New Patients

Experienced in WT1-Related Wilms Tumor Syndromes
White River Health System
White River Health System, Inc.
1710 Harrison St, 
Batesville, AR 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Atif Khan is a Hematologist and an Oncologist in Batesville, Arkansas. Dr. Khan is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Small Cell Lung Cancer (SCLC), Lung Cancer, and Lithotripsy. Dr. Khan is currently accepting new patients.

His clinical research consists of co-authoring 479 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology
Oncology
Licenses
Internal Medicine in AR
Hospital Affiliations
White River Medical Center
Stone County Medical Center
Languages Spoken
English
Urdu
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Arkansas Health and Wellness
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
HMO Partners
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Primewell Health Services
  • HMO
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE PART D
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

WHITE RIVER HEALTH SYSTEM, INC.
1710 Harrison St, Batesville, AR 72501
Call: 870-262-1200

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: November 10, 2025
Intervention Type: Other, Radiation, Drug
Study Drug: Temozolomide
Study Phase: Phase 2
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
Enrollment Status: Active_not_recruiting
Publish Date: October 08, 2025
Intervention Type: Other, Radiation
Study Phase: Phase 3
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: December 27, 2023
Intervention Type: Radiation
Study Phase: Not Applicable
Safety and Feasibility of Accelerated, Hypofractionated Radiotherapy in Women With Breast Cancer: A Phase II Trial
Safety and Feasibility of Accelerated, Hypofractionated Radiotherapy in Women With Breast Cancer: A Phase II Trial
Enrollment Status: Active_not_recruiting
Publish Date: August 03, 2023
Intervention Type: Radiation
Study Phase: Phase 2
TRI-fraction Radiotherapy Utilized to Minimize Patient Hospital Trips : A Phase II Trial (TRIUMPH-T Trial)
TRI-fraction Radiotherapy Utilized to Minimize Patient Hospital Trips : A Phase II Trial (TRIUMPH-T Trial)
Enrollment Status: Completed
Publish Date: May 15, 2023
Intervention Type: Other, Radiation
Study Phase: Phase 2
Accelerated, Hypofractionated Post-Mastectomy Radiation Therapy in Women With Breast Cancer: A Phase II Trial
Accelerated, Hypofractionated Post-Mastectomy Radiation Therapy in Women With Breast Cancer: A Phase II Trial
Enrollment Status: Completed
Publish Date: April 20, 2023
Intervention Type: Radiation
Study Phase: Phase 2
View 5 Less Clinical Trials

479 Total Publications

Adjuvant Radiation and Endocrine Therapy in Early-Stage Breast Cancer With Low Genomic Risk.
Adjuvant Radiation and Endocrine Therapy in Early-Stage Breast Cancer With Low Genomic Risk.
Journal: JAMA network open
Published: September 17, 2025
View All 479 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Ryan C. Koch
Oncology | Holistic Medicine
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Ryan C. Koch
Oncology | Holistic Medicine

White County Medical Center

415 Rodgers Dr, Suite A, 
Searcy, AR 
 (37.3 miles away)
501-278-3297
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ryan Koch is an Oncologist and a Holistic Medicine provider in Searcy, Arkansas. Mr. Koch is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Pleuropulmonary Blastoma, Lung Cancer, and Paget Disease of the Breast. Mr. Koch is currently accepting new patients.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Mazen Y. Khalil
Hematology Oncology | Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Mazen Y. Khalil
Hematology Oncology | Hematology | Oncology

Cancer Care Associates Inc

225 E Jackson Ave, 
Jonesboro, AR 
 (52.3 miles away)
870-207-8210
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mazen Khalil is a Hematologist Oncology specialist and a Hematologist in Jonesboro, Arkansas. Dr. Khalil is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Paget Disease of the Breast, Lung Cancer, Breast Cancer, Chronic Lymphocytic Leukemia (CLL), and Lymphadenectomy. Dr. Khalil is currently accepting new patients.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Marc Monte
Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Marc Monte
Oncology
300 Carson St, 
Jonesboro, AR 
 (52.5 miles away)
870-932-5296
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Marc Monte is an Oncologist in Jonesboro, Arkansas. Dr. Monte is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Hodgkin Lymphoma, and Chronic Lymphocytic Leukemia (CLL). Dr. Monte is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Khan's expertise for a condition
ConditionClose
    • Distinguished
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Khan is
      Distinguished
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Anemia
      Dr. Khan is
      Distinguished
      . Learn about Anemia.
      See more Anemia experts
    • Breast Cancer
      Dr. Khan is
      Distinguished
      . Learn about Breast Cancer.
      See more Breast Cancer experts
    • Colorectal Cancer
      Dr. Khan is
      Distinguished
      . Learn about Colorectal Cancer.
      See more Colorectal Cancer experts
    • EGFR Positive Lung Cancer
      Dr. Khan is
      Distinguished
      . Learn about EGFR Positive Lung Cancer.
      See more EGFR Positive Lung Cancer experts
    • Familial Colorectal Cancer
      Dr. Khan is
      Distinguished
      . Learn about Familial Colorectal Cancer.
      See more Familial Colorectal Cancer experts
    View All 16 Distinguished Conditions
    • Advanced
    • Chronic B-Cell Leukemia (CBCL)
      Dr. Khan is
      Advanced
      . Learn about Chronic B-Cell Leukemia (CBCL).
      See more Chronic B-Cell Leukemia (CBCL) experts
    • Chronic Lymphocytic Leukemia (CLL)
      Dr. Khan is
      Advanced
      . Learn about Chronic Lymphocytic Leukemia (CLL).
      See more Chronic Lymphocytic Leukemia (CLL) experts
    • Chronic Myelogenous Leukemia (CML)
      Dr. Khan is
      Advanced
      . Learn about Chronic Myelogenous Leukemia (CML).
      See more Chronic Myelogenous Leukemia (CML) experts
    • Familial Prostate Cancer
      Dr. Khan is
      Advanced
      . Learn about Familial Prostate Cancer.
      See more Familial Prostate Cancer experts
    • Follicular Lymphoma
      Dr. Khan is
      Advanced
      . Learn about Follicular Lymphoma.
      See more Follicular Lymphoma experts
    • Gastric Lymphoma
      Dr. Khan is
      Advanced
      . Learn about Gastric Lymphoma.
      See more Gastric Lymphoma experts
    View All 21 Advanced Conditions
    • Experienced
    • Acute Erythroid Leukemia (AEL)
      Dr. Khan is
      Experienced
      . Learn about Acute Erythroid Leukemia (AEL).
      See more Acute Erythroid Leukemia (AEL) experts
    • Acute Hepatic Porphyria (AHP)
      Dr. Khan is
      Experienced
      . Learn about Acute Hepatic Porphyria (AHP).
      See more Acute Hepatic Porphyria (AHP) experts
    • Acute Myeloblastic Leukemia with Maturation
      Dr. Khan is
      Experienced
      . Learn about Acute Myeloblastic Leukemia with Maturation.
      See more Acute Myeloblastic Leukemia with Maturation experts
    • Acute Myeloblastic Leukemia without Maturation
      Dr. Khan is
      Experienced
      . Learn about Acute Myeloblastic Leukemia without Maturation.
      See more Acute Myeloblastic Leukemia without Maturation experts
    • Acute Myeloid Leukemia (AML)
      Dr. Khan is
      Experienced
      . Learn about Acute Myeloid Leukemia (AML).
      See more Acute Myeloid Leukemia (AML) experts
    • Acute Myelomonocytic Leukemia
      Dr. Khan is
      Experienced
      . Learn about Acute Myelomonocytic Leukemia.
      See more Acute Myelomonocytic Leukemia experts
    View All 99 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved